- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Placebo (Saxagliptin)
Total 54159 results
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
Boehringer IngelheimCompleted
-
University of South CarolinaU.S. Army Medical Research and Development CommandCompletedSeaweed Associated Changes in Healthy SubjectsUnited States
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Zhujiang HospitalThird Affiliated Hospital, Sun Yat-Sen University; Peking University Shenzhen... and other collaboratorsCompletedType 2 Diabetes MellitusChina
-
Brigham and Women's HospitalCompletedChronic Kidney DiseaseUnited States
-
Stanley Dudrick's Memorial HospitalTerminated
-
Virginia Commonwealth UniversityJanssen Scientific Affairs, LLCCompletedDiabetes Mellitus, Type 2 | Heart Failure, SystolicUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2 | End-Stage Kidney Disease
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Japan Association for Diabetes Education and CareMerck Sharp & Dohme LLCCompleted
-
Chung-Ang UniversityUnknownDiabetes Mellitus, Type 2 | Acute Coronary SyndromeKorea, Republic of
-
Sun Yat-sen UniversityUnknownDiabetes Mellitus, Type 2
-
Nagaoka Red Cross HospitalUnknownType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP1941United States
-
Gladwin, Mark, MDNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedSedentary Lifestyle | Frailty | AgingUnited States
-
Mersin UniversityCompleted
-
John Paul II Hospital, KrakowNational Center for Research and Development, Poland; KCRIActive, not recruiting
-
John Paul II Hospital, KrakowNational Center for Research and Development, Poland; KCRICompleted
-
Vanderbilt UniversityCompletedHypertension | Type 2 Diabetes MellitusUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorUnited States
-
Boehringer IngelheimCompleted
-
Nanjing First Hospital, Nanjing Medical UniversityCompleted
-
The University of Hong KongCompletedType 2 Diabetes | KetonemiaHong Kong
-
Novartis PharmaceuticalsCompletedAcromegaly | Cushing's DiseaseUnited States, Turkey, Belgium, Thailand, Germany, Denmark, Russian Federation, Peru, China, Brazil, India, Poland
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus Type 2Korea, Republic of
-
Intarcia TherapeuticsCompletedType 2 DiabetesUnited States, Croatia, Latvia, Denmark, Germany
-
Wuhan General Hospital of Guangzhou Military CommandCompletedCoronary Artery Disease | Newly Diagnosed Type 2 DiabetesChina
-
Ludwig-Maximilians - University of MunichTerminated
-
Medanta, The Medicity, IndiaDiabetes & Endocrinology FoundationRecruiting
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruitingDecompensated Cirrhosis | Compensated CirrhosisIndia
-
Shanghai Zhongshan HospitalRecruitingCardiovascular Diseases | Type 2 Diabetes | Cardiac Perfusion DefectChina
-
Peking University People's HospitalRecruitingBlood Coagulation Disorders | Thrombocytopenia | Immune Thrombocytopenia | Physiological Effects of DrugsChina
-
SK Chemicals Co., Ltd.CompletedHealthy SubjectsKorea, Republic of
-
Kansai Electric Power HospitalSaiseikai Noe Hospital OsakaCompletedDiabetes Mellitus, Type 2Japan
-
Dokkyo Medical UniversityMerck Sharp & Dohme LLCUnknown
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, Turkey, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
Vanderbilt UniversityCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)
-
Dong Wha Pharmaceutical Co. Ltd.CompletedA Pharmacokinetic Study of DW6012 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult VolunteersHealthy SubjectsKorea, Republic of
-
Chinese PLA General HospitalUnknownAtherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1
-
University of DundeeCompletedDiabetes Mellitus, Type 2United Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
PfizerCompletedType 2 Diabetes MellitusUnited States
-
Intarcia TherapeuticsWithdrawnType 2 DiabetesUnited States
-
LG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
University Health Network, TorontoMerck Sharp & Dohme LLCCompleted